Category: biotech

.Merck &amp Co. has actually picked up options on two Evaxion Biotech vaccine applicants, paying out $3.2 million and hanging more than $1 billion in

.Merck &amp Co.’s long-running attempt to land a hit on little cell bronchi cancer (SCLC) has scored a tiny triumph. The drugmaker’s Daiichi Sankyo-partnered antibody-drug

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.’s HER3-directed antibody-drug conjugate (ADC) has actually hit its main endpoint, improving plannings to

.Gilead Sciences and Merck &amp Co. have actually helped their once-weekly HIV combination therapy past an additional landmark, connecting the drink to continual reductions of

.MBX has actually fleshed out plannings to consume over $136 thousand from its IPO as the biotech seeks to carry a potential challenger to Ascendis

.MBX Biosciences has added to the recent spurt of IPO filings. The biotech, which submitted its documents full weeks after increasing $63.5 million confidentially, is

.Complying with a bad showing for Lykos Therapeutics’ MDMA applicant for trauma at a current FDA advisory committee meeting, the various other shoe possesses dropped.On

.Psychopharmacology has actually pulled three write-ups regarding midstage scientific test data determining Lykos Therapies’ investigational MDMA candidate for handling post-traumatic stress disorder (POST-TRAUMATIC STRESS DISORDER).

.Lykos Rehabs may possess lost three-quarters of its own staff in the wake of the FDA’s rejection of its own MDMA prospect for post-traumatic stress

.Lundbeck has used Charles River Laboratories’ expert system capacities to help the discovery of neuroscience procedures, partnering with the specialist to use Logica in its